MSB Trading 2020 - a new dawn, page-8271

Agreed - spot on @dplane

"since no drug is ever perfectly safe or effective, the FDA is tasked with
determining when the benefits of a drug outweigh its disadvantages. On an even more challenging level, the FDA is forced to predict whether the future benefits of a drug will outweigh its future disadvantages. If the FDA is too conservative in approving new drugs, then
consumers are denied access to much-needed medicines, however, if the FDA is too liberal in approving new drugs, then consumers will be exposed to risky medicines. It is in striking a balance between these two extremes that the FDA reviews drug applications to approve or deny new drug applications, thereby affecting these drugs’ availability in the market."

How well did the FDA perform their task/ function in this instance with Ryoncil?

Surely, if we can see this, then someone with higher authority at the FDA can see this as well.

Way way way too officious!